Exane Derivatives Buys iShares MSCI Malaysia ETF, iShares MSCI Emerging Markets ETF, iShares MSCI China ETF, Sells UBS Group AG, Fiat Chrysler Automobiles NV, iShares MSCI Philippines ETF

Author's Avatar
Jan 22, 2020
Article's Main Image
Paris, I0, based Investment company Exane Derivatives (Current Portfolio) buys iShares MSCI Malaysia ETF, iShares MSCI Emerging Markets ETF, iShares MSCI China ETF, International Business Machines Corp, Linde PLC, sells UBS Group AG, Fiat Chrysler Automobiles NV, iShares MSCI Philippines ETF, Deutsche Bank AG, Ferrari NV during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Exane Derivatives. As of 2019Q4, Exane Derivatives owns 667 stocks with a total value of $528 million. These are the details of the buys and sells.

For the details of EXANE DERIVATIVES's stock buys and sells, go to https://www.gurufocus.com/guru/exane+derivatives/current-portfolio/portfolio

These are the top 5 holdings of EXANE DERIVATIVES
  1. UBS Group AG (UBS) - 2,654,394 shares, 6.58% of the total portfolio. Shares reduced by 40.81%
  2. iShares MSCI Emerging Markets ETF (EEM) - 484,115 shares, 4.19% of the total portfolio. Shares added by 88.17%
  3. iShares MSCI Taiwan ETF (EWT) - 372,835 shares, 2.91% of the total portfolio. Shares added by 46.43%
  4. VanEck Vectors ETF Trust - VanEck Vectors Russia E (RSX) - 542,029 shares, 2.67% of the total portfolio. Shares reduced by 16.19%
  5. Ferrari NV (RACE) - 82,399 shares, 2.46% of the total portfolio. Shares reduced by 43.92%
New Purchase: International Business Machines Corp (IBM)

Exane Derivatives initiated holding in International Business Machines Corp. The purchase prices were between $131.91 and $143, with an estimated average price of $135.78. The stock is now traded at around $139.17. The impact to a portfolio due to this purchase was 1.71%. The holding were 65,875 shares as of .

New Purchase: Freeport-McMoRan Inc (FCX)

Exane Derivatives initiated holding in Freeport-McMoRan Inc. The purchase prices were between $8.51 and $13.17, with an estimated average price of $11.05. The stock is now traded at around $12.27. The impact to a portfolio due to this purchase was 1.36%. The holding were 554,426 shares as of .

New Purchase: Lennar Corp (LEN)

Exane Derivatives initiated holding in Lennar Corp. The purchase prices were between $55.24 and $61.97, with an estimated average price of $58.95. The stock is now traded at around $64.94. The impact to a portfolio due to this purchase was 0.82%. The holding were 69,257 shares as of .

New Purchase: Polaris Inc (PII)

Exane Derivatives initiated holding in Polaris Inc. The purchase prices were between $82.03 and $103.44, with an estimated average price of $97.3. The stock is now traded at around $91.70. The impact to a portfolio due to this purchase was 0.71%. The holding were 40,077 shares as of .

New Purchase: Xerox Holdings Corp (XRX)

Exane Derivatives initiated holding in Xerox Holdings Corp. The purchase prices were between $28.31 and $39.3, with an estimated average price of $35.15. The stock is now traded at around $36.03. The impact to a portfolio due to this purchase was 0.67%. The holding were 96,322 shares as of .

New Purchase: Schlumberger Ltd (SLB)

Exane Derivatives initiated holding in Schlumberger Ltd. The purchase prices were between $30.71 and $40.79, with an estimated average price of $35.85. The stock is now traded at around $36.95. The impact to a portfolio due to this purchase was 0.41%. The holding were 57,123 shares as of .

Added: iShares MSCI Malaysia ETF (EWM)

Exane Derivatives added to a holding in iShares MSCI Malaysia ETF by 2155911.76%. The purchase prices were between $26.96 and $28.66, with an estimated average price of $27.76. The stock is now traded at around $28.40. The impact to a portfolio due to this purchase was 1.98%. The holding were 366,522 shares as of .

Added: iShares MSCI Emerging Markets ETF (EEM)

Exane Derivatives added to a holding in iShares MSCI Emerging Markets ETF by 88.17%. The purchase prices were between $39.43 and $45.07, with an estimated average price of $42.23. The stock is now traded at around $45.06. The impact to a portfolio due to this purchase was 1.96%. The holding were 484,115 shares as of .

Added: iShares MSCI China ETF (MCHI)

Exane Derivatives added to a holding in iShares MSCI China ETF by 28362.38%. The purchase prices were between $55.37 and $64.27, with an estimated average price of $59.97. The stock is now traded at around $65.00. The impact to a portfolio due to this purchase was 1.81%. The holding were 143,735 shares as of .

Added: Linde PLC (LIN)

Exane Derivatives added to a holding in Linde PLC by 1389.62%. The purchase prices were between $184.11 and $212.9, with an estimated average price of $201.93. The stock is now traded at around $211.73. The impact to a portfolio due to this purchase was 1.41%. The holding were 37,464 shares as of .

Added: Pan American Silver Corp (PAAS)

Exane Derivatives added to a holding in Pan American Silver Corp by 1360.77%. The purchase prices were between $15.54 and $23.8, with an estimated average price of $18.64. The stock is now traded at around $22.10. The impact to a portfolio due to this purchase was 1.05%. The holding were 261,770 shares as of .

Added: iShares MSCI Taiwan ETF (EWT)

Exane Derivatives added to a holding in iShares MSCI Taiwan ETF by 46.43%. The purchase prices were between $35.3 and $41.31, with an estimated average price of $38.64. The stock is now traded at around $40.84. The impact to a portfolio due to this purchase was 0.92%. The holding were 372,835 shares as of .

Sold Out: Anheuser-Busch InBev SA/NV (BUD)

Exane Derivatives sold out a holding in Anheuser-Busch InBev SA/NV. The sale prices were between $77.77 and $93.43, with an estimated average price of $83.04.

Sold Out: iShares MSCI Indonesia ETF (EIDO)

Exane Derivatives sold out a holding in iShares MSCI Indonesia ETF. The sale prices were between $23.58 and $25.72, with an estimated average price of $24.86.

Sold Out: Xerox Holdings Corp (XER2)

Exane Derivatives sold out a holding in Xerox Holdings Corp. The sale prices were between $26 and $35.4, with an estimated average price of $31.66.

Sold Out: ConocoPhillips (COP)

Exane Derivatives sold out a holding in ConocoPhillips. The sale prices were between $53.07 and $65.03, with an estimated average price of $58.97.

Sold Out: Spotify Technology SA (SPOT)

Exane Derivatives sold out a holding in Spotify Technology SA. The sale prices were between $112.52 and $154.15, with an estimated average price of $138.02.

Sold Out: Global Payments Inc (GPN)

Exane Derivatives sold out a holding in Global Payments Inc. The sale prices were between $155.13 and $183.49, with an estimated average price of $172.18.

Reduced: UBS Group AG (UBS)

Exane Derivatives reduced to a holding in UBS Group AG by 40.81%. The sale prices were between $10.58 and $12.58, with an estimated average price of $11.92. The stock is now traded at around $12.51. The impact to a portfolio due to this sale was -3.77%. Exane Derivatives still held 2,654,394 shares as of .

Reduced: Fiat Chrysler Automobiles NV (FCAU)

Exane Derivatives reduced to a holding in Fiat Chrysler Automobiles NV by 66.42%. The sale prices were between $12.27 and $16.19, with an estimated average price of $14.5. The stock is now traded at around $13.65. The impact to a portfolio due to this sale was -3.33%. Exane Derivatives still held 729,277 shares as of .

Reduced: iShares MSCI Philippines ETF (EPHE)

Exane Derivatives reduced to a holding in iShares MSCI Philippines ETF by 91.35%. The sale prices were between $32.55 and $36.3, with an estimated average price of $34.47. The stock is now traded at around $32.33. The impact to a portfolio due to this sale was -2.01%. Exane Derivatives still held 31,446 shares as of .

Reduced: Deutsche Bank AG (DB)

Exane Derivatives reduced to a holding in Deutsche Bank AG by 69.74%. The sale prices were between $6.92 and $8.08, with an estimated average price of $7.51. The stock is now traded at around $8.27. The impact to a portfolio due to this sale was -1.8%. Exane Derivatives still held 576,469 shares as of .

Reduced: Ferrari NV (RACE)

Exane Derivatives reduced to a holding in Ferrari NV by 43.92%. The sale prices were between $146.9 and $170.88, with an estimated average price of $162.17. The stock is now traded at around $174.15. The impact to a portfolio due to this sale was -1.51%. Exane Derivatives still held 82,399 shares as of .

Reduced: TechnipFMC PLC (FTI)

Exane Derivatives reduced to a holding in TechnipFMC PLC by 68.05%. The sale prices were between $18.56 and $23.51, with an estimated average price of $20.79. The stock is now traded at around $19.40. The impact to a portfolio due to this sale was -0.95%. Exane Derivatives still held 101,645 shares as of .



Here is the complete portfolio of EXANE DERIVATIVES. Also check out:

1. EXANE DERIVATIVES's Undervalued Stocks
2. EXANE DERIVATIVES's Top Growth Companies, and
3. EXANE DERIVATIVES's High Yield stocks
4. Stocks that EXANE DERIVATIVES keeps buying